TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Swedish registry study of nearly 1.46 million children found that parental autoimmune disease was associated with a higher risk of type 1 diabetes in offspring. The association was strongest when a parent had type 1 diabetes, but the observational study cannot establish cause and did not measure several factors that could affect risk.
A Swedish study of 1,455,645 children found that those whose parents had autoimmune disease were more likely to develop type 1 diabetes than children whose parents did not have those conditions. The association was strongest when a parent had type 1 diabetes, but the registry study shows a link, not proof that parental disease causes diabetes in a child.
The children were born in Sweden from 2001 to 2014 and were followed through 2023. Overall, maternal autoimmune disease during pregnancy was associated with a 57% higher hazard of type 1 diabetes in offspring (adjusted hazard ratio 1.57; 95% confidence interval 1.46–1.68). Paternal autoimmune disease before childbirth showed a similar association (adjusted hazard ratio 1.51; 95% confidence interval 1.37–1.67), according to the study, published in JAMA Pediatrics.
Estimates were higher when the parent had type 1 diabetes specifically. Maternal type 1 diabetes was associated with a hazard ratio of 4.51, while paternal type 1 diabetes was associated with a hazard ratio of 5.79. These figures compare hazards within the study population; they do not mean that most children of affected parents will develop the disease. The authors reported the highest risk among children with both parents affected.
The researchers also used cousin-comparison models to account for some shared familial factors. In that analysis, the association with maternal autoimmune disease remained statistically significant but was smaller: adjusted hazard ratio 1.27 (95% CI 1.08–1.50). The study included follow-up to a median age of 15.3 years, so it does not capture every case that could arise later in life.
Family History Can Flag Higher Risk
The findings may help clinicians and families understand why family history matters when considering a child’s risk of type 1 diabetes. The researchers said the broadly similar associations for maternal and paternal autoimmune disease point toward shared familial susceptibility, which may include inherited factors. The study does not identify a single mechanism or establish that a parent’s condition directly changes a child’s immune system.
In an accompanying editorial, Mikael Knip of Biomedicum Helsinki wrote that children with a family history of autoimmune disease are a risk group for progression to clinical type 1 diabetes and said screening and monitoring guidance exists. How consistently screening is available may vary with resources. The study itself did not test a screening program or show that screening prevents diabetes or improves outcomes.
Benjamin Nwosu, a pediatric endocrinologist at Northwell Health Cohen Children’s Medical Center who was not involved in the research, stressed the role of genetic susceptibility. He said the major histocompatibility complex class 2 region carries a substantial portion of genetic risk, while emphasizing that type 1 diabetes is polygenic rather than inherited in a simple, single-gene pattern. For readers, the practical point is that elevated relative risk is not a prediction that an individual child will develop the disease.
Products Worth Considering
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
Levoit Vital 100S-P Air Purifier with Washable Pre-Filter
Garmin Forerunner 70 GPS Running Smartwatch, 43 mm, Black
As an affiliate, we earn on qualifying purchases.
How the Swedish Study Was Conducted
The analysis drew on national registry records for children born in Sweden over a 14-year period. About 6.1% had a mother with an autoimmune disease recorded before delivery. The study compared maternal and paternal autoimmune conditions, including specific disease groups, and tracked diagnoses of type 1 diabetes in the children.
Across disease categories, the associations were not identical. The authors reported stronger paternal associations for endocrine autoimmune conditions, particularly autoimmune thyroiditis, while maternal associations were stronger for ankylosing spondylitis and gastrointestinal autoimmune disorders. They said this variation may fit a multifactorial account involving shared susceptibility and, for some conditions, possible parent-specific or pregnancy-related influences. Those explanations remain possibilities, not findings that the study directly confirmed.
The authors’ interpretation is consistent with the observation that both maternal and paternal autoimmune disease were associated with offspring risk. However, the cousin analysis suggests that some of the initial maternal association may reflect factors shared within families. The study cannot separate inherited biology, family environment and other influences completely.
“A clear gradient in type 1 diabetes risk was observed according to parental type 1 diabetes status, with the highest risk among offspring with both parents affected.”
— Xingbo Mo, PhD, of Karolinska Institutet, and co-authors
Limits on Interpreting the Risk
The study was observational, so it cannot establish that parental autoimmune disease caused type 1 diabetes in offspring. Although the researchers used cousin comparisons to account for some shared familial factors, those models cannot remove every potential source of confounding. The reported hazard ratios also describe relative associations, not a child’s individual probability of developing the condition.
The registries did not contain information on disease severity, autoantibody levels, disease activity during pregnancy or medication use. The researchers said these factors could affect fetal immune programming but could not be assessed. The results may also not apply equally to other populations: Nwosu noted that Sweden is at northern latitudes, where type 1 diabetes is common. The study does not determine whether the same estimates would be seen in countries with different populations or health systems.
It is also unclear which biological or environmental pathways account for the observed associations, why certain disease categories showed different maternal and paternal patterns, or whether monitoring based on family history changes outcomes. The study did not evaluate those questions.
Screening Guidance and Further Research
The findings add evidence for considering family autoimmune history when clinicians discuss type 1 diabetes risk, but they do not by themselves establish a new screening schedule. Knip referred to existing consensus guidance for screening and monitoring people at risk; clinicians and families would need to consider that guidance alongside local resources and individual circumstances.
Further research could test whether the observed patterns hold in populations outside Sweden and examine the roles of disease activity, autoantibodies, medications and specific genetic factors. Studies of screening would also be needed to determine whether identifying risk earlier leads to better clinical outcomes. Until then, the central finding remains an association in a large national cohort, with the strongest reported estimates among children whose parents had type 1 diabetes.
Key Questions
Does a parent’s autoimmune disease mean a child will develop type 1 diabetes?
No. The study found a higher relative risk among children whose parents had autoimmune disease, but it does not predict what will happen to any individual child or show that most such children develop diabetes.
Which parental condition had the strongest association?
Parental type 1 diabetes had the strongest reported association. The hazard ratio was 4.51 for maternal type 1 diabetes and 5.79 for paternal type 1 diabetes. These are relative study estimates, not absolute probabilities.
Did the study prove that autoimmune disease in a parent causes diabetes in a child?
No. This was an observational registry study. It found associations and used cousin comparisons to account for some shared family factors, but it cannot establish cause or rule out all confounding.
Should children with a family history be screened?
An accompanying editorial said offspring of parents with autoimmune disease warrant monitoring and noted that consensus screening guidance exists. The study did not test a screening program. Families should discuss individual risk and relevant guidance with a qualified health professional.
What important information was missing?
The researchers lacked registry data on parental disease severity, autoantibodies, disease activity during pregnancy and medication use. The study also cannot determine how well its estimates apply beyond Sweden.
Source: medpagetoday.com
